arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BALCHEM CORP

BCPC
$178.41 ▼ -4.20 (-2.30%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
18 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
79
Health
Good
Bullish
auto_awesome

Analytical Summary

BALCHEM CORP shows strong fundamentals with top-quartile Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.8B
Dividend Yield 0.54%
Revenue Growth 8.8% ↗
Op. Margin 20.2% ↗
ROIC 13.2% ↗
FCF / Share $6.71 ↗
Trailing P/E 37.2x
Price / Book 4.6x
FCF Yield 3.8%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.04B
↑ +8.8% —
Net Income Profit after all expenses
$154.84M
↑ +20.5% —
Operating Margin Operating profit as % of sales
20.2%
↑ +5.2% 75th
FCF / Share Free cash flow per share
$6.71
↑ +19.2% —
Long-Term Debt Long-term obligations
$156.00M
— —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
78
Returns ↑
74
Financial Health ↓
88
Cash Quality ↑
78

Dividend History

Dividend / share · sourced from SEC filings
$0.96 Latest / share
+10.3% YoY
+10.2% 3-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 69 quarters